Canada locks down an initial 500K doses of GSK's bird flu vaccine
The Public Health Agency of Canada has leveraged an existing deal with GSK to lock down an initial supply of 500,000 doses of the British drugmaker’s avian influenza vaccine for humans. Overall, 60% of available doses will be shipped out, with Canada holding back another 40% in a federal stockpile.
The Public Health Agency of Canada has leveraged an existing deal with GSK to lock down an initial supply of 500,000 doses of the British drugmaker’s avian influenza vaccine for humans. Overall, 60% of available doses will be shipped out, with Canada holding back another 40% in a federal stockpile.
